GLP-1 Receptor Agonists
Cagrilintide
$279.00
For Research Use Only. Not for human consumption. All products are sold strictly for in-vitro research and laboratory use.
Retatrutide is a triple agonist peptide targeting GIP, GLP-1, and glucagon receptors. Researched for metabolic regulation and body composition. Each vial contains lyophilized powder.
